Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19
Condition: COVID-19 Interventions: Biological: Low dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule; Biological: Low dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 14-day schedule; Biological: Medium dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule; Biological: Medium dosage Inactivat ed SARS-CoV-2 Vaccine on a 0- and 14-day schedule; Biological: High dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule; Biological: High dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 14-day schedule; Biological: Placebo on a 0- and 28-day schedule; Biological: Placebo on a 0- and 14-day schedule Sponsors: Chinese Academy of Medical Sciences; West China Second University Hospital; Yunnan Center for Disease Control and Prevention Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials